"Paid clinical trials enrolling now. Study medication and all study related care provided at no cost, no insurance needed. Compensation provided after every completed visit."

During the past decade, Centex Studies, Inc. conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 13 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 5 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centex Studies, Inc." #1 sponsor was "Pfizer" with 6 trials, followed by "Celgene" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Janssen Vaccines & Prevention B.V." with 2 trials sponsored and "Marius Pharmaceuticals" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centex Studies, Inc." #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Syneos Health" with 2 trials as a collaborator and "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Centex Studies, Inc." are "Crohn Disease" (3 trials), "COVID-19" (2 trials), "Cardiovascular Disease" (2 trials), "Diabetes Mellitus, Type 2" (2 trials) and "Hypogonadism, Male" (2 trials). Many other conditions were trialed in "Centex Studies, Inc." in a lesser frequency.

Most popular intervention types in "Centex Studies, Inc." are "Drug" (24 trials), "Biological" (5 trials), "Other" (5 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Ozanimod" (3 trials), "placebo" (3 trials), "Nitazoxanide" (2 trials) and "SOV2012-F1" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centex Studies, Inc." are 27 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centex Studies, Inc.". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Centex Studies, Inc., undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Centex Studies, Inc., 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".